A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice

MLA

Yasushi Sakata, et al. “A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice.” Journal of Atherosclerosis and Thrombosis, vol. 25, no. 2, Aug. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....62644f78df4e004e1e8a4ab61b51484b&authtype=sso&custid=ns315887.

APA

Yasushi Sakata, Shizuya Yamashita, Tohru Ohama, Makoto Nishida, Yinghong Zhu, Masami Sairyo, Takeshi Okada, Takuya Kobayashi, Koutaro Kanno, Daisaku Masuda, & Masahiro Koseki. (2017). A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice. Journal of Atherosclerosis and Thrombosis, 25(2).

Chicago

Yasushi Sakata, Shizuya Yamashita, Tohru Ohama, Makoto Nishida, Yinghong Zhu, Masami Sairyo, Takeshi Okada, et al. 2017. “A Novel Selective PPARα Modulator (SPPARMα), K-877 (Pemafibrate), Attenuates Postprandial Hypertriglyceridemia in Mice.” Journal of Atherosclerosis and Thrombosis 25 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....62644f78df4e004e1e8a4ab61b51484b&authtype=sso&custid=ns315887.